UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density

Bone (New York, N.Y.), 2010-07, Vol.47 (1), p.131-139

2010

Link zum Volltext

Verfügbarkeit prüfen

57: A Single Dose Study of Denosumab in Patients With Various Degrees of Renal Impairment

American journal of kidney diseases, 2010, Vol.55 (4), p.B46-B46

2010

Link zum Volltext

Verfügbarkeit prüfen

Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab

Osteoporosis international, 2019-12, Vol.30 (12), p.2437-2448

2019

Link zum Volltext

Verfügbarkeit prüfen

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

Osteoporosis international, 2015-12, Vol.26 (12), p.2773-2783

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of denosumab on the incidence of nonvertebral fractures in postmenopausal women at increased risk of fracture: A freedom study subanalysis (study sponsored by Amgen Inc)

Bone (New York, N.Y.), 2010-06, Vol.47, p.S213-S213

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates

Osteoporosis international, 2020, Vol.31 (1), p.181-191

2020

Link zum Volltext

Verfügbarkeit prüfen

Odanacatib treatment in postmenopausal women with low bone mineral density: 24-month results

Bone (New York, N.Y.), 2009-06, Vol.44, p.S438-S438

2009

Link zum Volltext

Verfügbarkeit prüfen

Relationship between baseline bone turnover marker levels and percent change in BMD at month 12 in postmenopausal women transitioned to denosumab or continuing on long-term alendronate therapy

Bone (New York, N.Y.), 2009-06, Vol.44, p.S435-S435

2009

Link zum Volltext

Verfügbarkeit prüfen

The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

Osteoporosis international, 2019-01, Vol.30 (1), p.71-78

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Hypocalcemia in Patients with Cancer Receiving Denosumab

Annals of oncology, 2014-09, Vol.25, p.iv529

2014

Link zum Volltext

Verfügbarkeit prüfen

FRI0289 Denosumab Treatment in Postmenopausal Women with Osteoporosis for Up to 9 Years: Results Through Year 6 of the Freedom Extension

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.529-530

2015

Link zum Volltext

Verfügbarkeit prüfen

OP0251 Effects of 2 Years of Treatment with Romosozumab Followed by 1 Year of Denosumab or Placebo in Postmenopausal Women with Low Bone Mineral Density

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.166-167

2015

Link zum Volltext

Verfügbarkeit prüfen

SAT0463 Effect of Eight Years of Denosumab Treatment in Postmenopausal Women with Osteoporosis: Five-Year Results from the Freedom Extension

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.761-761

2014

Link zum Volltext

Verfügbarkeit prüfen

SAT0342 Treatment of postmenopausal women with osteoporosis for six years with denosumab: Three-year results from the freedom extension

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.588-588

2013

Link zum Volltext

Verfügbarkeit prüfen

Dialysepflichtige Rhabdomyolyse 7 Tage nach Polytrauma

Der Anaesthesist, 2012-03, Vol.61 (3), p.224-228

2012

Link zum Volltext

Verfügbarkeit prüfen

1513PRISK FACTORS FOR HYPOCALCEMIA IN PATIENTS WITH CANCER RECEIVING DENOSUMAB

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv529-iv529

2014

Link zum Volltext

Verfügbarkeit prüfen

THERAPEUTIC ADMINISTRATION OF THORACIC EPIDURAL ANESTHESIA IN OVINE PULMONARY EMBOLISM

Anesthesia and analgesia, 1999-02, Vol.88 (2S), p.142

1999

Link zum Volltext

Verfügbarkeit prüfen

THE EFFECT OF NEOSTIGMINE ADDED TO AXILLARY BRACHIAL PLEXUS BLOCKADE

Anesthesia and analgesia, 1998-02, Vol.86 (2S), p.260

1998

Link zum Volltext

Verfügbarkeit prüfen

Hearing loss in Paget's disease of bone: The relationship between pure-tone thresholds and mineral density of the cochlear capsule

Hearing research, 1995, Vol.83 (1), p.114-120

1995

Link zum Volltext

Verfügbarkeit prüfen

The risk of subsequent osteoporotic fractures is decreased in patients experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

2017

Link zum Volltext

Verfügbarkeit prüfen

The risk of subsequent osteoporotic fractures is decreased in patients experiencing fracture while on denosumab

2016

Link zum Volltext

Verfügbarkeit prüfen

A randomized double-blind study of Denosumab (DMAB) compared with Zoledronic acid (ZOL) in postmenopausal women with osteoporosis previously treated with oral bisphosphonates

2016

Link zum Volltext

Verfügbarkeit prüfen

A randomized double-blind study of denosumab compared with zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonate

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
General & Internal Medicine
(8)
Human Health Sciences
(8)
Médecine Générale & Interne
(8)
Orthopedics
(8)
Sciences De La Santé Humaine
(8)
Endocrinology & Metabolism
(7)
Female
(7)
Humans
(7)
Middle Aged
(7)
Aged
(6)
Denosumab
(6)
Bone Density - Drug Effects
(5)
Fractures
(5)
Medicine
(5)
Medicine & Public Health
(5)
Osteoporosis
(5)
Osteoporosis, Postmenopausal - Drug Therapy
(5)
Aged, 80 And Over
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density

57: A Single Dose Study of Denosumab in Patients With Various Degrees of Renal Impairment

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

Effect of denosumab on the incidence of nonvertebral fractures in postmenopausal women at increased risk of fracture: A freedom study subanalysis (study sponsored by Amgen Inc)

Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates

Odanacatib treatment in postmenopausal women with low bone mineral density: 24-month results

Relationship between baseline bone turnover marker levels and percent change in BMD at month 12 in postmenopausal women transitioned to denosumab or continuing on long-term alendronate therapy

The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

Risk Factors for Hypocalcemia in Patients with Cancer Receiving Denosumab

FRI0289 Denosumab Treatment in Postmenopausal Women with Osteoporosis for Up to 9 Years: Results Through Year 6 of the Freedom Extension

OP0251 Effects of 2 Years of Treatment with Romosozumab Followed by 1 Year of Denosumab or Placebo in Postmenopausal Women with Low Bone Mineral Density

SAT0463 Effect of Eight Years of Denosumab Treatment in Postmenopausal Women with Osteoporosis: Five-Year Results from the Freedom Extension

SAT0342 Treatment of postmenopausal women with osteoporosis for six years with denosumab: Three-year results from the freedom extension

Dialysepflichtige Rhabdomyolyse 7 Tage nach Polytrauma

1513PRISK FACTORS FOR HYPOCALCEMIA IN PATIENTS WITH CANCER RECEIVING DENOSUMAB

THERAPEUTIC ADMINISTRATION OF THORACIC EPIDURAL ANESTHESIA IN OVINE PULMONARY EMBOLISM

THE EFFECT OF NEOSTIGMINE ADDED TO AXILLARY BRACHIAL PLEXUS BLOCKADE

Hearing loss in Paget's disease of bone: The relationship between pure-tone thresholds and mineral density of the cochlear capsule

The risk of subsequent osteoporotic fractures is decreased in patients experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

The risk of subsequent osteoporotic fractures is decreased in patients experiencing fracture while on denosumab

A randomized double-blind study of Denosumab (DMAB) compared with Zoledronic acid (ZOL) in postmenopausal women with osteoporosis previously treated with oral bisphosphonates

A randomized double-blind study of denosumab compared with zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonate

Ten years of Denosumab (DMAB) treatment in postmenopausal women with osteoporosis. Results from the FREEDOM Extension trial

Suchergebnisse filtern